Relationship Between Duodenal Histopathology and Strong Positive Tissue Transglutaminase Antibodies in Children with Celiac Disease

被引:1
|
作者
Dogan, Guzide [1 ]
Ayhan, Semin [2 ]
Yilmaz, Bilge [1 ]
Appak, Yeliz Cagan [1 ]
Dundar, Pinar Erbay [3 ]
Ecemis, Talat [4 ]
Unal, Fatih [5 ]
Kasirga, Erhun [1 ]
机构
[1] Celal Bayar Univ, Tip Fak, Cocuk Sagligi & Hastaliklari Anabilim Dali, Manisa, Turkey
[2] Celal Bayar Univ, Tip Fak, Patol Anabilim Dali, Manisa, Turkey
[3] Celal Bayar Univ, Tip Fak, Halk Sagligi Anabilim Dali, Manisa, Turkey
[4] Celal Bayar Univ, Tip Fak, Klin Mikrobiyol Anabilim Dali, Manisa, Turkey
[5] Dortcel Cocuk Hastanesi, Cocuk Hastaliklari Gastroenterol & Beslenme Dali, Bursa, Turkey
来源
关键词
Celiac disease; tissue transglutaminase antibody; duodenum; histopathology;
D O I
10.4274/jcp.81994
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: In celiac disease (CD) strong positive tissue transglutaminase antibody (TTGA) levels (> 100 U/A) have been shown to almost always indicate villous atrophy. The aim of this study is to determine the sufficiency of >= 100 U/A Ig A type TTGA levels for diagnosis of CD. Materials and Methods: Results from duodenum biopsy performed due to positive TTGA in 197 children were retrospectively examined. IgA TTGA levels had a positive value of > 18 U/A. Increases of 5 times or more than this threshold value (>= 100 U/A) are accepted as strong positivity. CD diagnosis was made according to ESPGHAN criteria. A modified Marsh stage >= 2 was accepted as significant for CD. Results: Of the cases, 129 were female (65.5%) and 68 were male (34.5%). Duodenum histopathology was compatible with Marsh 0 for 1 case (0.5%), Marsh 2 for 17 cases (8.6%), Marsh 3a for 41 (20.8%), Marsh 3b for 81 (41.4%) and Marsh 3c for 57 (28.9%). The TTGA levels of 64 of the 197 cases (32.5%) were >= 100 U/A. In cases with strong positivity for TTGA the duodenum histology was compatible with Marsh 3 (villous atrophy) for 63 and Marsh 0 (normal histology) for 1 case (type 1 diabetic and asymptomatic for CD). For Marsh 3c TTGA levels >= 100 U/A had a sensitivity of 85.96% (95% CI: 74.2-93.7%), specificity of 89.29% (95% CI: 82.9-93.8%), positive predictive value of 76.56% (95% CI: 64.3-86.2%) and negative predictive value of 93.9% (95% CI: 88.4-97.3%). Conclusions: This study showed that positive IgA TTGA levels (>= 100 U/A) were almost always accompanied by Marsh 3 duodenal histopathological changes. Diagnosis of CD without biopsy may miss certain accompanying diseases, however in some cases with advanced examinations CD may be diagnosed by pediatric gastroenterology specialists without endoscopy.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [41] The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments
    Sblattero, D
    Florian, F
    Azzoni, E
    Zyla, T
    Park, M
    Baldas, V
    Not, T
    Ventura, A
    Bradbury, A
    Marzari, R
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (21): : 5175 - 5181
  • [42] Tissue transglutaminase immunoglobulin isotypes in children with untreated and treated celiac disease
    Agardh, D
    Borulf, S
    Lernmark, Å
    Ivarsson, SA
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 36 (01): : 77 - 82
  • [43] Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease (vol 2016, 6718590, 2016)
    Hawamdeh, Hasan
    Al-Zoubi, Basim
    Al Sharqi, Yasameen
    Qasrawi, Ayman
    Abdel-Aziz, Yousef
    Barbar, Maha
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [44] Antitissue transglutaminase antibodies outside celiac disease
    Clemente, MG
    Musu, MP
    Frau, F
    Lucia, C
    De Virgiliis, S
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 34 (01): : 31 - 34
  • [45] Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes
    Bybrant, Mara Cerqueiro
    Uden, Elin
    Frederiksen, Filippa
    Gustafsson, Anna L.
    Arvidsson, Carl-Goran
    Fureman, Anna-Lena
    Forsander, Gun
    Larsson, Helena Elding
    Ivarsson, Sten A.
    Lindgren, Marie
    Ludvigsson, Johnny
    Marcus, Claude
    Lycka, Auste Pundziute
    Persson, Martina
    Samuelsson, Ulf
    Sarnblad, Stefan
    Akesson, Karin
    Ortqvist, Eva
    Carlsson, Annelie
    PEDIATRIC DIABETES, 2021, 22 (03) : 417 - 424
  • [46] Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies (vol 50, pg 27, 2018)
    Nurmi, R.
    Metso, M.
    Porsti, I.
    Niemela, O.
    Huhtala, H.
    Mustonen, J.
    Kaukinen, K.
    Makela, S.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (08) : 1207 - 1208
  • [47] Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members
    Parkkola, Anna
    Haerkoenen, Taina
    Ryhaenen, Samppa J.
    Uibo, Raivo
    Ilonen, Jorma
    Knip, Mikael
    PEDIATRIC DIABETES, 2018, 19 (02) : 305 - 313
  • [48] Tissue transglutaminase antibodies and celiac disease in patients with primary biliary cirrhosis and autoimmune cholangitis
    Chatzicostas, C
    Roussomoustakaki, M
    Drygiannakis, D
    Niniraki, M
    Koulentaki, M
    Tzardi, M
    Kouroumalis, EA
    GASTROENTEROLOGY, 2001, 120 (05) : A391 - A391
  • [49] Value of IgA antibodies to human recombinant tissue transglutaminase in the serological screening for celiac disease
    Tesei, N
    Sugai, E
    Selvaggio, E
    Vazquez, H
    Pizarro, B
    Pedreira, S
    Smecuol, E
    Niveloni, S
    Mazure, R
    La Motta, G
    Moreno, L
    Gomez, JC
    Maurino, E
    Bai, JC
    GASTROENTEROLOGY, 2002, 122 (04) : A182 - A182
  • [50] IgA Anti-Tissue Transglutaminase Antibodies, First Line in the Diagnosis of Celiac Disease
    Samasca, Gabriel
    Iancu, Mihaela
    Farcau, Dorin
    Butnariu, Angela
    Pop, Tudor
    Pirvan, Alexandru
    Andreica, Mariana
    Miu, Nicolae
    Cristea, Victor
    Dejica, Doru
    CLINICAL LABORATORY, 2011, 57 (9-10) : 695 - 701